{"transactions":[{"id":715813,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":32250,"kind":"person","name":"Majeti Jiangwen","position":1,"cik":"0002050150","reported_name":"Majeti Jiangwen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-07-06T17:10:35.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. The stock options will vest in equal 25% installments on the first, second, third and fourth anniversaries of July 1, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":100000,"derivative":{"exercise_price":1.75,"expiration_date":"2036-07-01","underlying":"Ordinary Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193125-26-295935","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2050150/000119312526295935/ownership.xml","form_type":"4"}},{"id":714373,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":31960,"kind":"person","name":"Qiu Min","position":1,"cik":"0002143654","reported_name":"Qiu Min","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2026-07-06T17:10:30.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. The stock options will vest in equal 25% installments on the first, second, third and fourth anniversaries of July 1, 2026, subject to the Reporting Person's continuous service with the Issuer through such dates."}],"balance_after":100000,"derivative":{"exercise_price":1.75,"expiration_date":"2036-07-01","underlying":"Ordinary Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193125-26-295934","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677940/000119312526295934/ownership.xml","form_type":"4"}},{"id":776572,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":46792,"kind":"person","name":"Huang Lan","position":1,"cik":"0001731317","reported_name":"Huang Lan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-05-15T20:13:11.000Z","date":"2026-03-20","kind":"gift","planned":false,"acquired":false,"shares":260582,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Lan Huang 2022 Grantor Retained Annuity Trust"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-226749","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677940/000119312526226749/ownership.xml","form_type":"4"}},{"id":812782,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":53286,"kind":"person","name":"Kirkby Matthew","position":1,"cik":"0002050147","reported_name":"Kirkby Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-08T20:57:26.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":23902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 1, 2027, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":23902,"derivative":{"exercise_price":1.64,"expiration_date":"2036-04-01","underlying":"Ordinary Shares","underlying_shares":23902},"source":{"system":"sec-edgar","filing":"0001193125-26-147830","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2050147/000119312526147830/ownership.xml","form_type":"4"}},{"id":816321,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-03T21:43:32.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":22165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 1, 2027, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":22165,"derivative":{"exercise_price":1.64,"expiration_date":"2036-04-01","underlying":"Ordinary Shares","underlying_shares":22165},"source":{"system":"sec-edgar","filing":"0001193125-26-142402","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000119312526142402/ownership.xml","form_type":"4"}},{"id":816488,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":53850,"kind":"person","name":"Delaney Brendan","position":1,"cik":"0001722585","reported_name":"Delaney Brendan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-03T20:24:46.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":20427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 1, 2027, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":20427,"derivative":{"exercise_price":1.64,"expiration_date":"2036-04-01","underlying":"Ordinary Shares","underlying_shares":20427},"source":{"system":"sec-edgar","filing":"0001193125-26-142218","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722585/000119312526142218/ownership.xml","form_type":"4"}},{"id":817159,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":32250,"kind":"person","name":"Majeti Jiangwen","position":1,"cik":"0002050150","reported_name":"Majeti Jiangwen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-03T20:24:38.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":21730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 1, 2027, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":21730,"derivative":{"exercise_price":1.64,"expiration_date":"2036-04-01","underlying":"Ordinary Shares","underlying_shares":21730},"source":{"system":"sec-edgar","filing":"0001193125-26-142217","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2050150/000119312526142217/ownership.xml","form_type":"4"}},{"id":817157,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":53918,"kind":"person","name":"Lu Yingjuan June","position":1,"cik":"0002050151","reported_name":"Lu Yingjuan June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (right to buy)","published_at":"2026-04-03T20:24:34.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":17840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. 4,460 of the stock options will vest on each of April 1, 2027, April 1, 2028, April 1, 2029 and April 1, 2030, subject to the Reporting Person's continuous service with the Issuer through such dates."}],"balance_after":17840,"derivative":{"exercise_price":1.64,"expiration_date":"2036-04-01","underlying":"Ordinary Shares","underlying_shares":17840},"source":{"system":"sec-edgar","filing":"0001193125-26-142216","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2050151/000119312526142216/ownership.xml","form_type":"4"}},{"id":815516,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":46792,"kind":"person","name":"Huang Lan","position":1,"cik":"0001731317","reported_name":"Huang Lan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2026-04-03T20:24:29.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":11514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. 2,878 of the stock options will vest on each of April 1, 2027, April 1, 2028 and April 1, 2029, and 2,880 of the stock options will vest on April 1, 2030, subject to the Reporting Person's continuous service with the Issuer through such dates."}],"balance_after":11514,"derivative":{"exercise_price":1.804,"expiration_date":"2031-04-01","underlying":"Ordinary Shares","underlying_shares":11514},"source":{"system":"sec-edgar","filing":"0001193125-26-142215","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677940/000119312526142215/ownership.xml","form_type":"4"}},{"id":817158,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":53919,"kind":"person","name":"Xu Sihai","position":1,"cik":"0002050149","reported_name":"Xu Sihai","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-04-03T20:24:24.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":18689,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 1, 2027, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":18689,"derivative":{"exercise_price":1.64,"expiration_date":"2036-04-01","underlying":"Ordinary Shares","underlying_shares":18689},"source":{"system":"sec-edgar","filing":"0001193125-26-142214","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2050149/000119312526142214/ownership.xml","form_type":"4"}},{"id":1015827,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-21T00:00:02.000Z","date":"2025-10-17","kind":"sale","planned":false,"acquired":false,"shares":45513,"price":1.76,"value":80102.88,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.80 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1518893,"source":{"system":"sec-edgar","filing":"0001231919-25-000335","document":"form4-10202025_111053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000335/form4-10202025_111053.xml","form_type":"4"}},{"id":1015826,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-21T00:00:02.000Z","date":"2025-10-16","kind":"sale","planned":false,"acquired":false,"shares":85798,"price":1.72,"value":147572.56,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.795 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1564406,"source":{"system":"sec-edgar","filing":"0001231919-25-000335","document":"form4-10202025_111053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000335/form4-10202025_111053.xml","form_type":"4"}},{"id":1018412,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-16T00:07:14.000Z","date":"2025-10-15","kind":"sale","planned":false,"acquired":false,"shares":17960,"price":1.65,"value":29634.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.60 to $1.685 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1650204,"source":{"system":"sec-edgar","filing":"0001231919-25-000323","document":"form4-10162025_121006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000323/form4-10162025_121006.xml","form_type":"4"}},{"id":1018411,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-16T00:07:14.000Z","date":"2025-10-14","kind":"sale","planned":false,"acquired":false,"shares":28495,"price":1.65,"value":47016.75,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1668164,"source":{"system":"sec-edgar","filing":"0001231919-25-000323","document":"form4-10162025_121006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000323/form4-10162025_121006.xml","form_type":"4"}},{"id":1018410,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-16T00:07:14.000Z","date":"2025-10-13","kind":"sale","planned":false,"acquired":false,"shares":107361,"price":1.7,"value":182513.7,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69 to $1.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1696659,"source":{"system":"sec-edgar","filing":"0001231919-25-000323","document":"form4-10162025_121006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000323/form4-10162025_121006.xml","form_type":"4"}},{"id":1020226,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-10T21:58:02.000Z","date":"2025-10-10","kind":"sale","planned":false,"acquired":false,"shares":2390,"price":1.77,"value":4230.3,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1804020,"source":{"system":"sec-edgar","filing":"0001231919-25-000308","document":"form4-10102025_091053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000308/form4-10102025_091053.xml","form_type":"4"}},{"id":1020225,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-10T21:58:02.000Z","date":"2025-10-09","kind":"sale","planned":false,"acquired":false,"shares":3979,"price":1.81,"value":7201.99,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.84 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1806410,"source":{"system":"sec-edgar","filing":"0001231919-25-000308","document":"form4-10102025_091053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000308/form4-10102025_091053.xml","form_type":"4"}},{"id":1020224,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-10T21:58:02.000Z","date":"2025-10-08","kind":"sale","planned":false,"acquired":false,"shares":7507,"price":1.77,"value":13287.39,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.74 to $1.805 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1810389,"source":{"system":"sec-edgar","filing":"0001231919-25-000308","document":"form4-10102025_091053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000308/form4-10102025_091053.xml","form_type":"4"}},{"id":1022148,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-07T22:14:58.000Z","date":"2025-10-07","kind":"sale","planned":false,"acquired":false,"shares":2100,"price":1.79,"value":3759.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.74 to $1.80 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1817896,"source":{"system":"sec-edgar","filing":"0001231919-25-000292","document":"form4-10072025_101049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000292/form4-10072025_101049.xml","form_type":"4"}},{"id":1022147,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-07T22:14:58.000Z","date":"2025-10-06","kind":"sale","planned":false,"acquired":false,"shares":17500,"price":1.78,"value":31150.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.7879 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1819996,"source":{"system":"sec-edgar","filing":"0001231919-25-000292","document":"form4-10072025_101049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000292/form4-10072025_101049.xml","form_type":"4"}},{"id":1022146,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-07T22:14:58.000Z","date":"2025-10-03","kind":"sale","planned":false,"acquired":false,"shares":600,"price":1.76,"value":1056.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.79 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1837496,"source":{"system":"sec-edgar","filing":"0001231919-25-000292","document":"form4-10072025_101049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000292/form4-10072025_101049.xml","form_type":"4"}},{"id":1027131,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-03T00:51:46.000Z","date":"2025-10-02","kind":"sale","planned":false,"acquired":false,"shares":600,"price":1.73,"value":1038.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.74 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1838096,"source":{"system":"sec-edgar","filing":"0001231919-25-000278","document":"form4-10032025_121037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000278/form4-10032025_121037.xml","form_type":"4"}},{"id":1027130,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-03T00:51:46.000Z","date":"2025-10-01","kind":"sale","planned":false,"acquired":false,"shares":2601,"price":1.8,"value":4681.8,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.785 to $1.81 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1838696,"source":{"system":"sec-edgar","filing":"0001231919-25-000278","document":"form4-10032025_121037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000278/form4-10032025_121037.xml","form_type":"4"}},{"id":1027129,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-03T00:51:46.000Z","date":"2025-09-30","kind":"sale","planned":false,"acquired":false,"shares":4464,"price":1.81,"value":8079.84,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.80 to $1.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1841297,"source":{"system":"sec-edgar","filing":"0001231919-25-000278","document":"form4-10032025_121037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000278/form4-10032025_121037.xml","form_type":"4"}},{"id":1031165,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-30T00:06:37.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":false,"shares":500,"price":1.75,"value":875.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.76 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1845761,"source":{"system":"sec-edgar","filing":"0001231919-25-000258","document":"form4-09302025_120929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000258/form4-09302025_120929.xml","form_type":"4"}},{"id":1031164,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-30T00:06:37.000Z","date":"2025-09-26","kind":"sale","planned":false,"acquired":false,"shares":600,"price":1.68,"value":1008.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.65 to $1.73 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1846261,"source":{"system":"sec-edgar","filing":"0001231919-25-000258","document":"form4-09302025_120929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000258/form4-09302025_120929.xml","form_type":"4"}},{"id":1031163,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-30T00:06:37.000Z","date":"2025-09-25","kind":"sale","planned":false,"acquired":false,"shares":700,"price":1.66,"value":1162.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.64 to $1.67 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1846861,"source":{"system":"sec-edgar","filing":"0001231919-25-000258","document":"form4-09302025_120929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000258/form4-09302025_120929.xml","form_type":"4"}},{"id":1033011,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-24T22:49:10.000Z","date":"2025-09-24","kind":"sale","planned":false,"acquired":false,"shares":2256,"price":1.68,"value":3790.08,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.67 to $1.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1847561,"source":{"system":"sec-edgar","filing":"0001231919-25-000244","document":"form4-09242025_100902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000244/form4-09242025_100902.xml","form_type":"4"}},{"id":1033010,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-24T22:49:10.000Z","date":"2025-09-23","kind":"sale","planned":false,"acquired":false,"shares":4106,"price":1.72,"value":7062.32,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.65 to $1.80 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1849817,"source":{"system":"sec-edgar","filing":"0001231919-25-000244","document":"form4-09242025_100902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000244/form4-09242025_100902.xml","form_type":"4"}},{"id":1033009,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-24T22:49:10.000Z","date":"2025-09-22","kind":"sale","planned":false,"acquired":false,"shares":5410,"price":1.83,"value":9900.3,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1853923,"source":{"system":"sec-edgar","filing":"0001231919-25-000244","document":"form4-09242025_100902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000244/form4-09242025_100902.xml","form_type":"4"}},{"id":1035524,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-19T22:03:12.000Z","date":"2025-09-19","kind":"sale","planned":false,"acquired":false,"shares":3656,"price":1.79,"value":6544.24,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.85 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1859333,"source":{"system":"sec-edgar","filing":"0001231919-25-000221","document":"form4-09192025_100903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000221/form4-09192025_100903.xml","form_type":"4"}},{"id":1035523,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-19T22:03:12.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":5307,"price":1.74,"value":9234.18,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1862989,"source":{"system":"sec-edgar","filing":"0001231919-25-000221","document":"form4-09192025_100903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000221/form4-09192025_100903.xml","form_type":"4"}},{"id":1035522,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-19T22:03:12.000Z","date":"2025-09-17","kind":"sale","planned":false,"acquired":false,"shares":2304,"price":1.83,"value":4216.32,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.80 to $1.88 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1868296,"source":{"system":"sec-edgar","filing":"0001231919-25-000221","document":"form4-09192025_100903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000221/form4-09192025_100903.xml","form_type":"4"}},{"id":1039294,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-16T23:45:49.000Z","date":"2025-09-16","kind":"sale","planned":false,"acquired":false,"shares":840,"price":1.88,"value":1579.2,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.86 to $1.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1870600,"source":{"system":"sec-edgar","filing":"0001736814-25-000007","document":"form4-09162025_110941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000173681425000007/form4-09162025_110941.xml","form_type":"4"}},{"id":1039293,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-16T23:45:49.000Z","date":"2025-09-15","kind":"sale","planned":false,"acquired":false,"shares":2570,"price":1.84,"value":4728.8,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.77 to $1.87 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1871440,"source":{"system":"sec-edgar","filing":"0001736814-25-000007","document":"form4-09162025_110941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000173681425000007/form4-09162025_110941.xml","form_type":"4"}},{"id":1039292,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-16T23:45:49.000Z","date":"2025-09-12","kind":"sale","planned":false,"acquired":false,"shares":700,"price":1.85,"value":1295.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.83 to $1.87 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1874010,"source":{"system":"sec-edgar","filing":"0001736814-25-000007","document":"form4-09162025_110941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000173681425000007/form4-09162025_110941.xml","form_type":"4"}},{"id":1042793,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-11T23:43:40.000Z","date":"2025-09-11","kind":"sale","planned":false,"acquired":false,"shares":3820,"price":1.9,"value":7258.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.87 to $1.94 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1874710,"source":{"system":"sec-edgar","filing":"0001415889-25-024317","document":"form4-09112025_110935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925024317/form4-09112025_110935.xml","form_type":"4"}},{"id":1042792,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-11T23:43:40.000Z","date":"2025-09-10","kind":"sale","planned":false,"acquired":false,"shares":8176,"price":1.93,"value":15779.68,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.90 to $2.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1878530,"source":{"system":"sec-edgar","filing":"0001415889-25-024317","document":"form4-09112025_110935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925024317/form4-09112025_110935.xml","form_type":"4"}},{"id":1042791,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-11T23:43:40.000Z","date":"2025-09-09","kind":"sale","planned":false,"acquired":false,"shares":9050,"price":1.97,"value":17828.5,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.90 to $2.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1886706,"source":{"system":"sec-edgar","filing":"0001415889-25-024317","document":"form4-09112025_110935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925024317/form4-09112025_110935.xml","form_type":"4"}},{"id":1045794,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-08T22:55:36.000Z","date":"2025-09-08","kind":"sale","planned":false,"acquired":false,"shares":7090,"price":1.93,"value":13683.7,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1895756,"source":{"system":"sec-edgar","filing":"0001415889-25-023907","document":"form4-09082025_100931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023907/form4-09082025_100931.xml","form_type":"4"}},{"id":1045793,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-08T22:55:36.000Z","date":"2025-09-05","kind":"sale","planned":false,"acquired":false,"shares":1106,"price":1.86,"value":2057.16,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.82 to $1.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1902846,"source":{"system":"sec-edgar","filing":"0001415889-25-023907","document":"form4-09082025_100931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023907/form4-09082025_100931.xml","form_type":"4"}},{"id":1045792,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-08T22:55:36.000Z","date":"2025-09-04","kind":"sale","planned":false,"acquired":false,"shares":803,"price":1.82,"value":1461.46,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.88 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1903952,"source":{"system":"sec-edgar","filing":"0001415889-25-023907","document":"form4-09082025_100931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023907/form4-09082025_100931.xml","form_type":"4"}},{"id":1049541,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-03T23:57:06.000Z","date":"2025-09-03","kind":"sale","planned":false,"acquired":false,"shares":1270,"price":1.81,"value":2298.7,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.84 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1904755,"source":{"system":"sec-edgar","filing":"0001415889-25-023607","document":"form4-09032025_110901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023607/form4-09032025_110901.xml","form_type":"4"}},{"id":1049540,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-03T23:57:06.000Z","date":"2025-09-02","kind":"sale","planned":false,"acquired":false,"shares":2800,"price":1.78,"value":4984.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.67 to $1.84 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1906025,"source":{"system":"sec-edgar","filing":"0001415889-25-023607","document":"form4-09032025_110901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023607/form4-09032025_110901.xml","form_type":"4"}},{"id":1049539,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-03T23:57:06.000Z","date":"2025-08-29","kind":"sale","planned":false,"acquired":false,"shares":800,"price":1.74,"value":1392.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.80 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1908825,"source":{"system":"sec-edgar","filing":"0001415889-25-023607","document":"form4-09032025_110901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023607/form4-09032025_110901.xml","form_type":"4"}},{"id":1053551,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-29T00:39:13.000Z","date":"2025-08-28","kind":"sale","planned":false,"acquired":false,"shares":809,"price":1.81,"value":1464.29,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.82 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1909625,"source":{"system":"sec-edgar","filing":"0001415889-25-023258","document":"form4-08292025_120807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023258/form4-08292025_120807.xml","form_type":"4"}},{"id":1053550,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-29T00:39:13.000Z","date":"2025-08-27","kind":"sale","planned":false,"acquired":false,"shares":1300,"price":1.78,"value":2314.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.82 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1910434,"source":{"system":"sec-edgar","filing":"0001415889-25-023258","document":"form4-08292025_120807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023258/form4-08292025_120807.xml","form_type":"4"}},{"id":1053549,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-29T00:39:13.000Z","date":"2025-08-26","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":1.79,"value":3580.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.76 to $1.84 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1911734,"source":{"system":"sec-edgar","filing":"0001415889-25-023258","document":"form4-08292025_120807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023258/form4-08292025_120807.xml","form_type":"4"}},{"id":1056798,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-25T23:46:54.000Z","date":"2025-08-25","kind":"sale","planned":false,"acquired":false,"shares":300,"price":1.77,"value":531.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.78 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1913734,"source":{"system":"sec-edgar","filing":"0001415889-25-022967","document":"form4-08252025_110849.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022967/form4-08252025_110849.xml","form_type":"4"}},{"id":1056797,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-25T23:46:54.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":2376,"price":1.75,"value":4158.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.77 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1914034,"source":{"system":"sec-edgar","filing":"0001415889-25-022967","document":"form4-08252025_110849.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022967/form4-08252025_110849.xml","form_type":"4"}},{"id":1056796,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-25T23:46:54.000Z","date":"2025-08-21","kind":"sale","planned":false,"acquired":false,"shares":3034,"price":1.79,"value":5430.86,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.74 to $1.86 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1916410,"source":{"system":"sec-edgar","filing":"0001415889-25-022967","document":"form4-08252025_110849.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022967/form4-08252025_110849.xml","form_type":"4"}},{"id":1060206,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-20T22:35:28.000Z","date":"2025-08-20","kind":"sale","planned":false,"acquired":false,"shares":3456,"price":1.74,"value":6013.44,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.76 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1919444,"source":{"system":"sec-edgar","filing":"0001415889-25-022532","document":"form4-08202025_100823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022532/form4-08202025_100823.xml","form_type":"4"}},{"id":1060205,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-20T22:35:28.000Z","date":"2025-08-19","kind":"sale","planned":false,"acquired":false,"shares":3604,"price":1.77,"value":6379.08,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.85 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1922900,"source":{"system":"sec-edgar","filing":"0001415889-25-022532","document":"form4-08202025_100823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022532/form4-08202025_100823.xml","form_type":"4"}},{"id":1060204,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-20T22:35:28.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":47668,"price":2.03,"value":96766.04,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.85 to $2.04 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1926504,"source":{"system":"sec-edgar","filing":"0001415889-25-022532","document":"form4-08202025_100823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022532/form4-08202025_100823.xml","form_type":"4"}},{"id":1065270,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-15T23:11:59.000Z","date":"2025-08-15","kind":"sale","planned":false,"acquired":false,"shares":2900,"price":2,"value":5800.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1974172,"source":{"system":"sec-edgar","filing":"0001415889-25-022119","document":"form4-08152025_110853.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022119/form4-08152025_110853.xml","form_type":"4"}},{"id":1065269,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-15T23:11:59.000Z","date":"2025-08-14","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":2,"value":4000.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares vat each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1977072,"source":{"system":"sec-edgar","filing":"0001415889-25-022119","document":"form4-08152025_110853.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022119/form4-08152025_110853.xml","form_type":"4"}},{"id":1070145,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-08-04","kind":"sale","planned":false,"acquired":false,"shares":2196,"price":2.18,"value":4787.28,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":891734,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070144,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-18","kind":"sale","planned":false,"acquired":false,"shares":900,"price":2.2,"value":1980.0,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":893930,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070143,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-17","kind":"sale","planned":false,"acquired":false,"shares":20572,"price":2.19,"value":45052.68,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":894830,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070142,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-16","kind":"sale","planned":false,"acquired":false,"shares":5396,"price":2.24,"value":12087.04,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":915402,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070141,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-15","kind":"sale","planned":false,"acquired":false,"shares":2152,"price":2.28,"value":4906.56,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":920798,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070140,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-14","kind":"sale","planned":false,"acquired":false,"shares":801,"price":2.29,"value":1834.29,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":922950,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070139,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-11","kind":"sale","planned":false,"acquired":false,"shares":246,"price":2.29,"value":563.34,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":923751,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070138,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-10","kind":"sale","planned":false,"acquired":false,"shares":768,"price":2.28,"value":1751.04,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":923997,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070137,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-09","kind":"sale","planned":false,"acquired":false,"shares":252,"price":2.27,"value":572.04,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":924765,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070136,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-08","kind":"sale","planned":false,"acquired":false,"shares":9059,"price":2.29,"value":20745.11,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":925017,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070135,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-02","kind":"sale","planned":false,"acquired":false,"shares":324,"price":2.42,"value":784.08,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":934076,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070134,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-01","kind":"sale","planned":false,"acquired":false,"shares":600,"price":2.43,"value":1458.0,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":934400,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070133,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-06-23","kind":"sale","planned":false,"acquired":false,"shares":1700,"price":3.09,"value":5253.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $3.06 to $3.19 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund II, L.P. (\"Fund II\"). Decheng Capital Management II (Cayman), LLC (\"GP II\") is the general partner of Fund II. Dr. Cui is the manager of GP II. Each of Fund II, GP II and Dr. Cui may be deemed to beneficially own the securities held by Fund II. Each of GP II and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1617409,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070132,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-06-20","kind":"sale","planned":false,"acquired":false,"shares":225217,"price":3.16,"value":711685.72,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $3.05 to $3.27 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund II, L.P. (\"Fund II\"). Decheng Capital Management II (Cayman), LLC (\"GP II\") is the general partner of Fund II. Dr. Cui is the manager of GP II. Each of Fund II, GP II and Dr. Cui may be deemed to beneficially own the securities held by Fund II. Each of GP II and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1619109,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070131,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-06-20","kind":"sale","planned":false,"acquired":false,"shares":60000,"price":3.11,"value":186600.0,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":935000,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070130,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-06-18","kind":"sale","planned":false,"acquired":false,"shares":59253,"price":3.17,"value":187832.01,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $3.10 to $3.34 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund II, L.P. (\"Fund II\"). Decheng Capital Management II (Cayman), LLC (\"GP II\") is the general partner of Fund II. Dr. Cui is the manager of GP II. Each of Fund II, GP II and Dr. Cui may be deemed to beneficially own the securities held by Fund II. Each of GP II and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1844326,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070129,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-06-17","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":3.23,"value":16150.0,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":995000,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1167206,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":53286,"kind":"person","name":"Kirkby Matthew","position":1,"cik":"0002050147","reported_name":"Kirkby Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-04-23T13:00:36.000Z","date":"2025-04-21","kind":"grant","planned":false,"acquired":true,"shares":25763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 21, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":25763,"derivative":{"exercise_price":1.31,"expiration_date":"2035-04-21","underlying":"Ordinary Shares","underlying_shares":25763},"source":{"system":"sec-edgar","filing":"0000950170-25-056990","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2050147/000095017025056990/ownership.xml","form_type":"4"}},{"id":1166981,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":46792,"kind":"person","name":"Huang Lan","position":1,"cik":"0001731317","reported_name":"Huang Lan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (right to buy)","published_at":"2025-04-23T13:00:05.000Z","date":"2025-04-21","kind":"grant","planned":false,"acquired":true,"shares":43630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 21, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":43630,"derivative":{"exercise_price":1.441,"expiration_date":"2030-04-21","underlying":"Ordinary Shares","underlying_shares":43630},"source":{"system":"sec-edgar","filing":"0000950170-25-056989","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677940/000095017025056989/ownership.xml","form_type":"4"}},{"id":1167112,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":53850,"kind":"person","name":"Delaney Brendan","position":1,"cik":"0001722585","reported_name":"Delaney Brendan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-04-23T12:59:42.000Z","date":"2025-04-21","kind":"grant","planned":false,"acquired":true,"shares":21822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 21, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":21822,"derivative":{"exercise_price":1.31,"expiration_date":"2035-04-21","underlying":"Ordinary Shares","underlying_shares":21822},"source":{"system":"sec-edgar","filing":"0000950170-25-056988","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722585/000095017025056988/ownership.xml","form_type":"4"}},{"id":1167209,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":32250,"kind":"person","name":"Majeti Jiangwen","position":1,"cik":"0002050150","reported_name":"Majeti Jiangwen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-04-23T12:58:46.000Z","date":"2025-04-21","kind":"grant","planned":false,"acquired":true,"shares":23300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 21, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":23300,"derivative":{"exercise_price":1.31,"expiration_date":"2035-04-21","underlying":"Ordinary Shares","underlying_shares":23300},"source":{"system":"sec-edgar","filing":"0000950170-25-056987","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2050150/000095017025056987/ownership.xml","form_type":"4"}},{"id":1167208,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":53919,"kind":"person","name":"Xu Sihai","position":1,"cik":"0002050149","reported_name":"Xu Sihai","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-04-23T12:58:25.000Z","date":"2025-04-21","kind":"grant","planned":false,"acquired":true,"shares":19852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 21, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":19852,"derivative":{"exercise_price":1.31,"expiration_date":"2035-04-21","underlying":"Ordinary Shares","underlying_shares":19852},"source":{"system":"sec-edgar","filing":"0000950170-25-056986","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2050149/000095017025056986/ownership.xml","form_type":"4"}},{"id":1167090,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":53837,"kind":"person","name":"Fabbio Patrick","position":1,"cik":"0001658859","reported_name":"Fabbio Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-04-23T12:58:04.000Z","date":"2025-04-21","kind":"grant","planned":false,"acquired":true,"shares":23793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 21, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":23793,"derivative":{"exercise_price":1.31,"expiration_date":"2035-04-21","underlying":"Ordinary Shares","underlying_shares":23793},"source":{"system":"sec-edgar","filing":"0000950170-25-056985","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658859/000095017025056985/ownership.xml","form_type":"4"}},{"id":1167207,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":53918,"kind":"person","name":"Lu Yingjuan June","position":1,"cik":"0002050151","reported_name":"Lu Yingjuan June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (right to buy)","published_at":"2025-04-23T12:57:35.000Z","date":"2025-04-21","kind":"grant","planned":false,"acquired":true,"shares":18981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 21, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":18981,"derivative":{"exercise_price":1.31,"expiration_date":"2035-04-21","underlying":"Ordinary Shares","underlying_shares":18981},"source":{"system":"sec-edgar","filing":"0000950170-25-056984","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2050151/000095017025056984/ownership.xml","form_type":"4"}}]}